Pricing Log in Create free account

Alumis Inc. (ALMS) vs Ginkgo Bioworks Holdings, Inc. (DNA)

Alumis Inc. and Ginkgo Bioworks Holdings, Inc. are both Biotechnology companies. Alumis Inc. and Ginkgo Bioworks Holdings, Inc. are of similar size ($842.4M and $791.9M). Ginkgo Bioworks Holdings, Inc. has the higher net margin (−219.6% vs −5,933.5%) and the lower return on invested capital (−161.9% vs 0.00%). Across the 15 metrics below, Ginkgo Bioworks Holdings, Inc. leads on 10 and Alumis Inc. on 5.

Valuation

Metric ALMS DNA Biotechnology median
P/E n/m n/m 8.50
P/S 105.63 4.82 9.71
P/B 1.73 1.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 37.74 2.99 9.21
Earnings yield (63.07%) (48.78%) (33.15%)
Free cash flow yield (45.02%) (27.32%) (25.50%)

Profitability

Metric ALMS DNA Biotechnology median
Gross margin 100.00% 68.04% 65.16%
Operating margin (6,204.39%) (231.13%) 0.00%
Net margin (5,933.45%) (219.60%) 0.00%
Free cash flow margin (4,755.33%) (131.57%) 0.00%
Return on equity (93.65%) (56.29%) (56.36%)
Return on assets (74.94%) (26.19%) (48.04%)
Return on invested capital 0.00% (161.94%) 0.00%

Growth

Metric ALMS DNA Biotechnology median
Revenue growth (TTM) — (37.02%) 6.02%
EPS growth (last fiscal year) 72.45% 46.49% 30.26%
Revenue growth, 5-year CAGR — 17.29% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ALMS DNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.74 4.57 4.72
Net debt to EBITDA 0.69 1.63 0.96

Dividend

Metric ALMS DNA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALMS DNA Biotechnology median
Market cap 842.35m 791.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack